854 related articles for article (PubMed ID: 29296139)
1. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
[TBL] [Abstract][Full Text] [Related]
2. Predictors for Uptake of Vaccines Offered during the Second Year of Life: Second Dose of Measles-Containing Vaccine and Meningococcal Serogroup A-Containing Vaccine, Ghana, 2020.
Muhoza P; Shah MP; Gao H; Amponsa-Achiano K; Quaye P; Opare W; Okae C; Aboyinga PN; Opare KL; Wardle MT; Wallace AS
Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896919
[TBL] [Abstract][Full Text] [Related]
3. Descriptive study of measles vaccination second dose reporting and barriers to improving coverage in six districts in Malawi.
Chirwa G; Wilkins KA; Mercer DJ
Pan Afr Med J; 2020; 35(Suppl 1):5. PubMed ID: 32373256
[TBL] [Abstract][Full Text] [Related]
4. Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa.
Manandhar P; Wannemuehler K; Danovaro-Holliday MC; Nic Lochlainn L; Shendale S; Sodha SV
Vaccine; 2023 Jan; 41(1):61-67. PubMed ID: 36396512
[TBL] [Abstract][Full Text] [Related]
5. Global Routine Vaccination Coverage, 2018.
Peck M; Gacic-Dobo M; Diallo MS; Nedelec Y; Sodha SV; Wallace AS
MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(42):937-942. PubMed ID: 31647786
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Impact of Meningococcal Serogroup A Conjugate Vaccine Introduction on Second-Year-of-Life Vaccination Coverage in Burkina Faso.
Zoma RL; Walldorf JA; Tarbangdo F; Patel JC; Diallo AO; Nkwenkeu SF; Kambou L; Nikiema M; Ouedraogo A; Bationo AB; Ouili R; Badolo H; Sawadogo G; Krishnaswamy A; Hatcher C; Hyde TB; Aké F; Novak RT; Wannemuehler K; Mirza I; Medah I; Soeters HM
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S233-S243. PubMed ID: 31671442
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with non-uptake of measles-rubella vaccine second dose among children under five years in Mtwara district council, Tanzania, 2017.
Magodi R; Mmbaga EJ; Massaga J; Lyimo D; Mphuru A; Abade A
Pan Afr Med J; 2019; 33():67. PubMed ID: 31448029
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China.
Hu Y; Chen Y; Wang Y; Liang H
Hum Vaccin Immunother; 2018 Apr; 14(4):875-880. PubMed ID: 29252094
[TBL] [Abstract][Full Text] [Related]
9. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
[TBL] [Abstract][Full Text] [Related]
10. Status of New Vaccine Introduction - Worldwide, September 2016.
Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
[TBL] [Abstract][Full Text] [Related]
11. Multi-level determinants of failure to receive timely and complete measles vaccinations in Southwest China: a mixed methods study.
Tang XY; Cheng M; Geater A; Deng QY; Zhong G; Lin YD; Chen N; Lan T; Jiang LY; Zhu MT; Li Q
Infect Dis Poverty; 2021 Jul; 10(1):102. PubMed ID: 34294157
[TBL] [Abstract][Full Text] [Related]
12. Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.
Rosenthal J; Rodewald L; McCauley M; Berman S; Irigoyen M; Sawyer M; Yusuf H; Davis R; Kalton G
Pediatrics; 2004 Apr; 113(4):e296-302. PubMed ID: 15060256
[TBL] [Abstract][Full Text] [Related]
13. Progress Toward Measles Elimination - Pakistan, 2000-2018.
Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
[TBL] [Abstract][Full Text] [Related]
14. Second dose of measles-containing vaccine coverage and associated factors among children aged 24-36 months in Gondar city, Central Gondar, Northwest Ethiopia, 2023.
Adisu MA; Bogale WA; Alemu TG
Front Public Health; 2024; 12():1364865. PubMed ID: 38756896
[TBL] [Abstract][Full Text] [Related]
15. How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? - evidence from Nigeria.
Sato R
Hum Vaccin Immunother; 2024 Dec; 20(1):2355036. PubMed ID: 38783606
[TBL] [Abstract][Full Text] [Related]
16. Vaccination coverage in Lebanon following the Syrian crisis: results from the district-based immunization coverage evaluation survey 2016.
Mansour Z; Hamadeh R; Rady A; Danovaro-Holliday MC; Fahmy K; Said R; Brandt L; Warrak R; Ammar W
BMC Public Health; 2019 Jan; 19(1):58. PubMed ID: 30642314
[TBL] [Abstract][Full Text] [Related]
17. Timeliness vaccination of measles containing vaccine and barriers to vaccination among migrant children in East China.
Hu Y; Li Q; Luo S; Lou L; Qi X; Xie S
PLoS One; 2013; 8(8):e73264. PubMed ID: 24013709
[TBL] [Abstract][Full Text] [Related]
18. Progress Toward Measles Elimination - European Region, 2009-2018.
Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
[TBL] [Abstract][Full Text] [Related]
19. Global Routine Vaccination Coverage, 2015.
Casey RM; Dumolard L; Danovaro-Holliday MC; Gacic-Dobo M; Diallo MS; Hampton LM; Wallace AS
MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(45):1270-1273. PubMed ID: 27855146
[TBL] [Abstract][Full Text] [Related]
20. Health workers' perceptions and challenges in implementing meningococcal serogroup a conjugate vaccine in the routine childhood immunization schedule in Burkina Faso.
Nkwenkeu SF; Jalloh MF; Walldorf JA; Zoma RL; Tarbangdo F; Fall S; Hien S; Combassere R; Ky C; Kambou L; Diallo AO; Krishnaswamy A; Aké FH; Hatcher C; Patel JC; Medah I; Novak RT; Hyde TB; Soeters HM; Mirza I
BMC Public Health; 2020 Feb; 20(1):254. PubMed ID: 32075630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
